Small intestinal bacterial overgrowth (SIBO) is commonly seen in the presence of one or more predisposing conditions. It varies highly based on the underlying disorders and microbiota characteristics of patients and organisms. SIBO results in gastrointestinal IBS-like symptoms, which could be asymptomatic. In worse cases, it may result in real malabsorption syndrome. The presence of SIBO is generally diagnosed with hydrogen lactulose and glucose breath tests. These tests are widely performed in every clinical setting due to their low costs, non-invasively, sufficient accuracy, and reproducibility.
This report contains market size and forecasts of Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics in Global, including the following market information:
Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hydrogen-predominant SIBO Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics include Genova Diagnostics, SIBO Diagnostics, Commonwealth Diagnostics International, Aerodiagnostics, LLC, SIBOTest, Metabolic Solutions, Inc., Pivotal Diagnostics, DirectLabs, LLC and Vibrant Wellness and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Segment Percentages, by Type, 2021 (%)
Hydrogen-predominant SIBO
Methane-predominant SIBO
Recurrent SIBO
Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Segment Percentages, by Application, 2021 (%)
Hospitals
Physician Clinics
Others
Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Genova Diagnostics
SIBO Diagnostics
Commonwealth Diagnostics International
Aerodiagnostics, LLC
SIBOTest
Metabolic Solutions, Inc.
Pivotal Diagnostics
DirectLabs, LLC
Vibrant Wellness
Health Associates Medical Group